loading page

The Outcome of Immune thrombocytopenic purpura in childhood and the risk factors for chronicity
  • +4
  • Baris Yilmaz,
  • Ahmet Koc,
  • Omer Dogru,
  • Burcu Tufan Tas,
  • emel senay,
  • Nurşah Eker,
  • Gulnur Tokuc
Baris Yilmaz
Marmara University Training and Research Hospital

Corresponding Author:[email protected]

Author Profile
Ahmet Koc
Marmara University School of Medicine
Author Profile
Omer Dogru
Marmara University School of Medicine
Author Profile
Burcu Tufan Tas
Marmara University Training and Research Hospital
Author Profile
emel senay
Marmara University Training and Research Hospital
Author Profile
Nurşah Eker
Marmara University School of Medicine
Author Profile
Gulnur Tokuc
Marmara University School of Medicine
Author Profile

Abstract

Abstract: Immune thrombocytopenic purpura (ITP) is an autoimmune disease presents with isolated thrombocytopenia (thrombocyte count < 100.000/mm3) and develops due to increased thrombocyte destruction by autoantibodies. ITP is the most common cause of pediatric thrombocytopenia. Usually a self-limiting disease with an acute course of 70% - 80%. However, 20% - 25% cases are chronical. These cases are follow-up and management difficult and expensive. It is important to distinguish events that may become chronic at the time of initial diagnosis. In this study, we sought clues to be able to choose, which the patient will be chronicle?
Nov 2021Published in Hematology, Transfusion and Cell Therapy volume 43 on pages S22. 10.1016/j.htct.2021.10.985